Dr Rupinder Kanwar

STAFF PROFILE

Position

Senior Lecturer in Biomedicine

Faculty

Faculty of Health

Department

School of Medicine

Campus

Geelong Waurn Ponds Campus

Contact

Biography summary

Qualifications
• Ph. D. (Medical Microbiology and Immunology), - Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
• M. Sc. (Medical Microbiology)-Punjab Agricultural University, India.
• B.Sc. (Medical) Punjab University, India.

Research Profile

Dr Rupinder K Kanwar has expertise in the field of biomedicine, especially interdisciplinary work on targeting cancer and chronic inflammation. After her PhD, Dr Kanwar’s multiaward winning research career has focussed on studying the molecular mechanisms and devising treatments for human chronic inflammatory diseases such as atherosclerosis, asthma, multiple sclerosis, bacterial diahhrea / gut health and cancer (colon, breast, liver, prostate, melanoma, retinoblastoma and brain) by employing both in vivo and in vitro models.

She has worked- in India, New Zealand and Australia, in a variety of positions (from postdoctoral to senior scientist positions), supporting and building new research programs related to interdisciplinary research, international collaborations and initiatives in the fields ranging from biomedicine to nanomedicine. She has 17 years’ experience in drug discovery targeting cancer and chronic inflammation, and delivered both academic and industry-oriented research outcomes.

Dr Kanwar’s current research interests focus on targeting molecular pathogenesis of cancer, cardiotoxicity and chronic inflammation, through drug discovery and pharmacogenomics leading to nanodrug and nanodiagnostic developments.

Her team’s research focus is Bench ↔Bedside biomedical research and innovative nanomedicine (emerging area in the future medicine), by employing established and patient derived biological specimens as well as cutting edge techniques of molecular biology, cell biology, immunology, nanobiotechnology, and protein chemistry.

Summary of HDR supervision at Deakin (since 2008)

As a Principal supervisor = 12 HDR students (10 PhD (includes 3 DIRI) + 2 MSc by Research),
Completions PhD =7, MSc= 1
As an Associate supervisor and co-supervisor = 21 HDR students (including 7 DIRI students, I TERI student)

Honours Supervision Completions/ Graduations
• Bachelors of Honours degree completion as a Principal-supervisor =1
• Bachelors of Honours degree completion as a Co-supervisor = 8

Masters of Biotechnology (Honours) project completions (as an associate supervisor) =4

Memberships of Professional Societies/Industry and Government Consortium

• 2016: British Society for Nanomedicine
• 2011-Present: Australian Nanotechnology Network (group membership)
• 2010- Present: Life membership of The Indian Academy of Tropical Parasitology, India.
• 2010- Present: Life membership of Indian Association of Medical Microbiology, India.
• 2010-2012: Membership of Inflammation Research Association (IRA) USA.
• 2010: Membership of Australasian Society for Immunology, Australia. 
• 2002-2006: Immune Team Membership of LactoPharma Consortium, New Zealand. LactoPharma was an exciting milk bioactives discovery joint venture between Fonterra Co-operative Group Limited, New Zealand and Auckland UniServices Limited. It was supported by the investment from New Zealand's Foundation for Research Science and Technology (FRST) and Fonterra NZ.
• 1994-Present: Life membership of Indian Society for Veterinary Immunology and Biotechnology, India.

Research interests

Dr RK Kanwar has expertise in applying cutting edge techniques of immunology, cell biology, molecular biology to study the pathophysiology and therapeutic targets of human cancer and chronic inflammatory diseases (atherosclerosis, asthma and multiple sclerosis) in both in vivo and in vitro models. Dr Kanwar also has skills in delivering industry oriented research and is a key inventor  on number of recent patent applications on devising treatments for chronic inflammatory diseases. Her current research focus is on combining nanomedicinal approaches with basic cell biology and immunology research, to devise diagnostics and therapeutics for cancer drug resistance, stemcells,  and chronic inflammatory disease (atherosclerosis and osteoarthritis).

Teaching interests

Cell and tissue engineering, Nanomedicine, Molecular pathogenesis oif disease,

Units taught

2015-2016: HMM305 Cell and Tissue Engineering (Unit Chair & lecturer)
2013-2016: HMO303 Health and Vision Sciences 2 (Guest Lecturer)
2013: HBS 400 Med Innovation (Unit chair)
2013: Bachelor of Medicine Bachelor of Surgery (BMBS) Year 1
(Guest Lecturer Cardio-respiratory Physiology)
2013: HMH 401 Developing Research Skills (Assessment Panel Member)
2012: SEK302 Nanomedicine (Assessment Panel Member)
2009-2011: SBB320 Nanobiotechnology (Unit Co-Chair, Lecturer, Assessment Panel Member)
2008-2009: SEK302 Nanomedicine (Unit Co-Chair and Guest Lecturer)
2008: SBB320 Nanobiotechnology (Unit Co-Chair, Assessment Panel Member and Guest Lecturer)
2008: SBB706 Frontier Techniques in Biotechnology and Nanotechnology (Guest Lecturer)
2006-2007: SBB323 Immunology (Lecturer).
2007: SBB234 Microbiology (Guest Lecturer).

Problem Based Learning (PBL) facilitator for Bachelor Medicine Bachelor of Surgery,

• Brain and Behaviour (2016)
• Infection Defence Repair (2015),
• Cardio-respiratory Physiology (2014)


Teaching at the University of Auckland, New Zealand
2006: MEDSCI 708 Advanced Immunology and Immunotherapy.
2002-2005: Molecular Medicine 712 (Advanced Immunology).
2000-2001: Integrin Signalling in Molecular Medicine 545.70

Professional activities

• Editorial board member, Future Science OA (UK)
• Editorial advisory board member Recent Patents on Anti-Infective Drug Discovery
• Manuscript reviewer for ten peer reviewed journals including PloS One, Journal Pharmacology and Experimental Therapeutics [American Society for Pharmacology and Experimental Therapeutics (ASPET), Current Medicinal Chemistry, Journal of Nanomaterials; Evidence-based Complementary and Alternative Medicine (eCAM) 
• Conference organising committee member and Moderator: 5th Asia-Pacific Summit on Cancer 2015, Brisbane, Australia.
• Scientific organizing committee member & symposium Co- chair 17th, Inflammation Research Association conference in USA, 2012.
• Poster judging panel member for 17th, Inflammation Research Association conference in USA, 2012.
• Grant application assessor for NHMRC; and Research Grant Council (RGC) of Hong Kong. 2010.
• Invited speaker and session chair/co-chair at national & international conferences since 2009.
• 2003-2006: Member of the Animal Resource Unit (ARU) Management committee of the University of Auckland, New Zealand (2003-March 2006)
At Deakin
• 2012-present: HDR Candidature confirmation panel member for BioDeakin, ITRI/IFM and School of Medicine.
• 2008-2011: HDR co-ordinator for BioDeakin in ITRI and IFM.

Awards

2015: Vice-Chancellor’s Award for Excellence in Research Supervision (Highly Commended).

2013: Vice Chancellor’s Award for Outstanding Contribution to Deakin Connectedness

2011. Selection for Deakin “Academic Women Aspiring to Leadership (AWAL)” Program.

2010: Charles River Competition “The Most Therapeutic Potential category award” at 16th International Inflammation Research Association Conference, Washington Dulles, Chantilly, Virginia. USA, (September 26-29). (The abstract # 112 was also selected for symposium’s invited presentation).


2005: Travel award Department of Molecular Medicine & Pathology, Faculty of Medicine and Health Science, The University of Auckland, New Zealand.

2004: Poster presentation award at the Conference of the International Society for Cancer Gene Therapy, Singapore. Work was also selected for an oral presentation (21 & 22 February 2004).

2003: Travel grant award Department of Molecular Medicine & Pathology, Faculty of Medicine and Health Science, University of Auckland New Zealand.

2003: Travel grant award Maurice and Phyllis Paykel Trust, New Zealand.

1995- 1996: Research Associateship* Department of Veterinary Immunology, College of Veterinary Sciences, Punjab Agricultural University (PAU), Ludhiana, India.

1993-1994: Senior Research Fellowship* Department of Veterinary Immunology, College of Veterinary Sciences, Punjab Agricultural University (PAU), Ludhiana, India.

March 1993 –Nov 1993: Senior Research Fellowship* Department of Experimental Medicine & Biotechnology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

August 1992-Feb 1992: PGIMER, Directors’ Fellowship award, India.

Jan1989 - July 1992: Junior Research Fellowship, Indian Council of Medical Research Postgraduate fellowship award, Department of Experimental Medicine & Biotechnology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

*These were All India Merit Early Career Research Fellowship awards from CSIR, India equivalent to DECRA (ARC) and NHMRC career development awards such as Peter Doherty in Australia.

1985: B.Sc. Medical  Merit list 25th rank (in Top 1% of total candidates in Punjab state, India) in the Punjab University, India.

1984: Class Topper Award for B.Sc.Year II in Khalsa College for Women, India.

1982-1983: Merit Scholarship Award of Punjab University Chandigarh, India, (BSc Medical).

1981-1982: Khalsa Diwan Merit Scholarship for B.Sc. Medical Year I.


 

Publications

Filter by

2017

Chasing the personalized medicine dream through biomarker validation in colorectal cancer.

H Patil, S Saxena, C Barrow, J Kanwar, A Kapat, R Kanwar

(2017), Vol. 22, pp. 111-119, Drug discovery today, Amsterdam, The Netherlands, C1

journal

SurR9C84A protects and recovers human cardiomyocytes from hypoxia induced apoptosis

A Ashok, J Kanwar, U Krishnan, R Kanwar

(2017), Vol. 350, pp. 19-31, Experimental cell research, Amsterdam, The Netherlands, C1

journal

Targeted theranostics against solid cancer using metal bond milk protein and aptamers

S Chaudhary, R Kanwar, J Kanwar

(2017), Vol. 17, pp. 2100-2111, Current topics in medicinal chemistry, Bussum, The Netherlands, C1

journal

Topical ophthalmic formulation of Trichostatin A and SurR9-C84A for quick recovery post-alkali burn of corneal haze

K Roy, C Cheung, R Kanwar, R Sandhir, J Kanwar

(2017), Vol. 8, pp. 1-15, Experimental pharmacology and drug discovery, Lausanne, Switzerland, C1

journal

Integrated 3D printed scaffolds and electrical stimulation for enhancing primary human cardiomyocyte cultures

S Adams, A Ashok, R Kanwar, J Kanwar, A Kouzani

(2017), Vol. 6, pp. 18-24, Bioprinting, Amsterdam, The Netherlands, C1

journal

Progress on azadirachta indica based biopesticides in replacing synthetic toxic pesticides

S Chaudhary, R Kanwar, A Sehgal, D Cahill, C Barrow, R Sehgal, J Kanwar

(2017), Vol. 8, pp. 1-13, Frontiers in plant science, Lausanne, Switzerland, C1

journal

Neocarzinostatin, aptamer conjugates for targeting EpCAM-positive tumor cells

P Athyala, J Kanwar, S Chitipothu, R Kanwar, S Krishnakumar, J Watson, J Narayanan

(2017), Vol. 37, pp. 3615-3629, Anticancer research, Kapandriti Attica, Greece, C1

journal

Aged macular degeneration: current therapeutics for management and promising new drug candidates.

Afrah Abd, Rupinder Kanwar, Jagat Kanwar

(2017), Vol. 22, pp. 1671-1679, Drug Discov Today, England, C1

journal
2016

Probing the biophysical interaction between Neocarzinostatin toxin and EpCAM RNA aptamer

P Athyala, J Kanwar, M Alameen, R Kanwar, S Krishnakumar, J Watson, U Vetrivel, J Narayanan

(2016), Vol. 469, pp. 257-262, Biochemical and biophysical research communications, Amsterdam, The Netherlands, C1

journal

Antiparasitic and immunomodulatory potential of oral nanocapsules encapsulated lactoferrin protein against plasmodium berghei

N Anand, R Kanwar, R Sehgal, J Kanwar

(2016), Vol. 11, pp. 47-62, Nanomedicine, London, Eng., C1

journal

Ultra-small algal chitosan ocular nanoparticles with iron-binding milk protein prevents the toxic effects of carbendazim pesticide

P Sunkireddy, R Kanwar, J Ram, J Kanwar

(2016), Vol. 11, pp. 495-511, Nanomedicine, London, Eng., C1

journal

Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells

K Roy, Y Patel, R Kanwar, R Rajkhowa, X Wang, J Kanwar

(2016), Vol. 11, pp. 25-44, International journal of nanomedicine, Macclesfield, Eng., C1

journal

Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents

R Chaudhary, K Roy, R Kanwar, K Walder, J Kanwar

(2016), Vol. 14, pp. 1-17, Journal of nanobiotechnology, London, Eng., C1

journal

Multimodal iron oxide (Fe?O?)-saturated lactoferrin nanocapsules as nanotheranostics for real-time imaging and breast cancer therapy of claudin-low, triple-negative (ER-/PR-/HER2-)

J Kanwar, S Kamalapuram, S Krishnakumar, R Kanwar

(2016), Vol. 11, pp. 249-268, Nanomedicine, London, Eng., C1

journal

Comparative activities of milk components in reversing chronic colitis

J Kanwar, R Kanwar, S Stathopoulos, N Haggarty, A MacGibbon, K Palmano, K Roy, A Rowan, G Krissansen

(2016), Vol. 99, pp. 2488-2501, Journal of dairy science, Atlanta, Ga., C1

journal

Multimodal nanomedicine strategies for targeting cancer cells as well as cancer stem cell signalling mechanisms

J Kanwar, R Samarasinghe, S Kamalapuram, R Kanwar

(2016), pp. 1-8, Mini reviews in medicinal chemistry, Beijing, China, C1

journal

Survivin modulators: an updated patent review (2011-2015)

K Roy, N Singh, R Kanwar, J Kanwar

(2016), Vol. 11, pp. 152-169, Recent patents on anti-cancer drug discovery, Beijing, China, C1

journal

Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers

S Kamalapuram, R Kanwar, K Roy, R Chaudhary, R Sehgal, J Kanwar

(2016), Vol. 11, pp. 1349-1366, International journal of nanomedicine, Macclesfield, Eng., C1

journal

Targeting CD44, ABCG2 and CD133 markers using aptamers: in silico analysis of CD133 extracellular domain 2 and its aptamer

N Subramanian, B Akilandeswari, A Bhutra, M Alameen, U Vetrivel, V Khetan, R Kanwar, J Kanwar, S Krishnakumar

(2016), Vol. 6, pp. 32115-32123, RSC advances, Cambridge, Eng., C1

journal

Studies to prevent degradation of recombinant fc-fusion protein expressed in mammalian cell line and protein characterization

S Chakrabarti, C Barrow, R Kanwar, V Ramana, J Kanwar

(2016), Vol. 17, pp. 1-22, International journal of molecular sciences, Basel, Switzerland., C1

journal

A study of gene expression of survivin, its antiapoptotic variants, and targeting survivin in vitro for therapy in retinoblastoma

J Samuel, R Kanwar, J Kanwar, V Khetan, S Krishnakumar

(2016), Vol. 38, pp. e230-e242, Journal of pediatric hematology/oncology, Philadelphia, Pa., C1

journal

Ophthalmic combination of SurR9-C84A and trichostatin-A targeting molecular pathogenesis of alkali burn

K Roy, B Sriramoju, R Kanwar, J Kanwar

(2016), Vol. 7, pp. 1-14, Frontiers in Pharmacology, Lausanne, Switzerland, C1

journal

Doxorubicin conjugated to immunomodulatory anticancer lactoferrin displays improved cytotoxicity overcoming prostate cancer chemo resistance and inhibits tumour development in TRAMP mice

J Shankara Narayanan, J Kanwar, A Al-Juhaishi, R Kanwar

(2016), Vol. 6, pp. 1-16, Scientific reports, London, Eng., C1

journal

Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry-based imaging

N Subramanian, A Srimany, J Kanwar, R Kanwar, B Akilandeswari, P Rishi, V Khetan, M Vasudevan, T Pradeep, S Krishnakumar

(2016), Vol. 5, pp. 1-11, Molecular therapy : nucleic acids, Amsterdam, The Netherlands, C1

journal

Nanotheranostic based iron oxide (Fe?O?) saturated lactoferrin nanocapsules for colonic adenocarcinoma

S Kamalapuram, R Kanwar, J Kanwar

(2016), Vol. 12, pp. 1758-1773, Journal of biomedical nanotechnology, Valencia, Calif., C1

journal

E-cadherin aptamer-conjugated delivery of doxorubicin for targeted inhibition of prostate cancer cells

R Chaudhary, K Roy, R Kanwar, R Veedu, S Krishnakumar, C Cheung, A Verma, J Kanwar

(2016), Vol. 69, pp. 1108-1116, Australian journal of chemistry, Clayton, Vic., C1

journal
2015

Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc

J Kanwar, V Mahidhara, K Roy, S Sasidharan, S Krishnakumar, N Prasad, R Sehgal, R Kanwar

(2015), Vol. 10, pp. 35-55, Nanomedicine, London, United Kingdom, C1

journal

Lactoferrin induced neuronal differentiation: A boon for brain tumours.

B Sriramoju, R Kanwar, J Kanwar

(2015), Vol. 41, pp. 28-36, International Journal of Developmental Neuroscience, England, C1

journal

Blocking the maturation of OncomiRNAs using pri-miRNA-17?92 aptamer in retinoblastoma

N Subramanian, J Kanwar, R Kanwar, S Krishnakumar

(2015), Vol. 25, pp. 47-52, Nucleic acid therapeutics, New Rochelle, N. Y., C1

journal

Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model

K Roy, R Kanwar, S Krishnakumar, C Cheung, J Kanwar

(2015), Vol. 10, pp. 1019-1043, International journal of nanomedicine, Auckland, N. Z., C1

journal

Nucleic acid-based aptamers: applications, development and clinical trials

J Kanwar, K Roy, N Maremanda, K Subramanian, R Veedu, R Bawa, R Kanwar

(2015), Vol. 22, pp. 2539-2557, Current medicinal chemistry, Bussum, The Netherlands, C1

journal

Nanoformulated mutant SurR9-C84A: a possible key for alzheimer's and its associated inflammation

B Sriramoju, R Kanwar, J Kanwar

(2015), Vol. 32, pp. 2787-2797, Pharmaceutical research, New York, N. Y., C1

journal

EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex

N Subramanian, J Kanwar, P Athalya, N Janakiraman, V Khetan, R Kanwar, S Eluchuri, S Krishnakumar

(2015), Vol. 22, pp. 1-10, Journal of biomedical science, London, Eng., C1

journal

Evaluation of nanoformulated therapeutics in an ex-vivo bovine corneal irritation model

B Sriramoju, K Roy, R Kanwar, J Kanwar

(2015), Vol. 29, pp. 917-925, Toxicology in vitro, Amsterdam, The Netherlands, C1

journal

Aptamer-targeted oligonucleotide theranostics: a smarter approach for brain delivery and the treatment of neurological diseases

B Sriramoju, R Kanwar, R Veedu, J Kanwar

(2015), Vol. 15, pp. 1115-1124, Current topics in medicinal chemistry, Bussum, The Netherlands, C1

journal

Locked nucleic acid modified bi-specific aptamer-targeted nanoparticles carrying survivin antagonist towards effective colon cancer therapy

K Roy, R Kanwar, C Antonio Cheung, C Lee Fleming, R Veedu, S Krishnakumar, J Kanwar

(2015), Vol. 5, pp. 29008-29016, RSC advances, Cambridge, Eng., C1

journal

Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery

N Subramanian, J Kanwar, B Akilandeswari, R Kanwar, V Khetan, S Krishnakumar

(2015), Vol. 51, pp. 6940-6943, Chemical communications, Cambridge, Eng., C1

journal

Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer

J Gibbons, J Kanwar, R Kanwar

(2015), Vol. 15, pp. 1-16, BMC cancer, London, Eng., C1

journal

Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions

J Kanwar, K Roy, Y Patel, S-F Zhou, M Singh, D Singh, M Nasir, R Sehgal, A Sehgal, R Singh, S Garg, R Kanwar

(2015), Vol. 20, pp. 9703-9731, Molecules, Basel, Switzerland, C1-1

journal

Cissus quadrangularis inhibits IL-1? induced inflammatory responses on chondrocytes and alleviates bone deterioration in osteotomized rats via p38 MAPK signaling

J Kanwar, R Samarasinghe, K Kumar, R Arya, S Sharma, S Zhou, S Sasidharan, R Kanwar

(2015), Vol. 9, pp. 2927-2940, Drug Design, Development and Therapy, [Auckland, N.Z.], C1

journal

Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism

G Mahidhara, R Kanwar, K Roy, J Kanwar

(2015), Vol. 10, pp. 4081-4098, International journal of nanomedicine, Auckland, N. Z., C1

journal

EpCAM Aptamer-siRNA chimera targets and regress epithelial cancer

N Subramanian, J Kanwar, R Kanwar, J Sreemanthula, J Biswas, V Khetan, S Krishnakumar

(2015), Vol. 10, pp. 1-19, PLoS one, San Francisco, Calif., C1

journal

Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: promising potential for targeting radiosensitive retinoblastoma

J Samuel, N Singh, J Kanwar, S Krishnakumar, R Kanwar

(2015), Vol. 139, pp. 108-114, Experimental eye research, Amsterdam, The Netherlands, C1

journal

Effect of lactoferrin protein on red blood cells and macrophages: mechanism of parasite-host interaction

N Anand, R Kanwar, M Dubey, R Vahishta, R Sehgal, A Verma, J Kanwar

(2015), Vol. 9, pp. 3821-3835, Drug design develeopment and therapy, Auckland, N.Z, C1

journal

Brain targeted PLGA nanocarriers alleviating amyloid-? expression and preserving basal survivin in degenerating mice model

B Sriramoju, P Neerati, R Kanwar, J Kanwar

(2015), Vol. 1852, pp. 2423-2431, Biochimica et biophysica acta, Amsterdam, The Netherlands, C1

journal

LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging

K Roy, R Kanwar, J Kanwar

(2015), Vol. 71, pp. 84-99, Biomaterials, Amsterdam, The Netherlands, C1

journal

Molecular targets in arthritis and recent trends in nanotherapy

K Roy, R Kanwar, J Kanwar

(2015), Vol. 10, pp. 5407-5420, International journal of nanomedicine, Auckland, N. Z., C1

journal

Targeting cancer cells using LNA-modified aptamer-siRNA chimeras

N Subramanian, J Kanwar, R Kanwar, S Krishnakumar

(2015), Vol. 25, pp. 317-322, Nucleic acid therapeutics, New Rochelle, N.Y., C1

journal

Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondii

N Anand, R Sehgal, R Kanwar, M Dubey, R Vasishta, J Kanwar

(2015), Vol. 10, pp. 6355-6369, International journal of nanomedicine, Auckland, New Zealand, C1

journal

Neurobehavioral burden of multiple sclerosis with nanotheranostics

B Sriramoju, R Kanwar, J Kanwar

(2015), Vol. 11, pp. 2675-2689, Neuropsychiatric disease and treatment, Auckland, New Zealand, C1

journal

Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells

N Maremanda, K Roy, R Kanwar, V Shyamsundar, V Ramshankar, A Krishnamurthy, S Krishnakumar, J Kanwar

(2015), Vol. 9, pp. 1-20, Biomicrofluidics, Maryland, United States, C1

journal

Role of nanomedicine in arthritic disorders

R Samarasinghe, R Kanwar, J Kanwar

(2015), Vol. 1, pp. 281-311, NanoBioMedicine Vol. 1: Nanomedicine, Houston, Tex., B1-1

chapter
2014

Current protein-based anti-angiogenic therapeutics

S Chakrabarti, C Barrow, R Kanwar, V Ramana, J Kanwar

(2014), Vol. 14, pp. 291-312, Mini-reviews in medicinal chemistry, Bussum, The Netherlands, C1

journal

Aptamer-based therapeutics of the past, present and future: from the perspective of eye-related diseases

J Kanwar, J Shankaranarayanan, S Gurudevan, R Kanwar

(2014), Vol. 19, pp. 1309-1321, Drug discovery today, Amsterdam, The Netherlands, C1

journal

Antiarthritic and chondroprotective activity of Lakshadi Guggul in novel alginate-enclosed chitosan calcium phosphate nanocarriers

R Samarasinghe, R Kanwar, K Kumar, J Kanwar

(2014), Vol. 9, pp. 819-837, Nanomedicine, London, England, C1

journal

The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis

R Samarasinghe, R Kanwar, J Kanwar

(2014), Vol. 35, pp. 7522-7534, Biomaterials, Amsterdam, The Netherlands, C1

journal

Identification of unprecedented anticancer properties of high molecular weight biomacromolecular complex containing bovine lactoferrin (HMW-bLf)

F Ebrahim, J Shankaranarayanan, J Kanwar, S Gurudevan, U Krishnan, R Kanwar

(2014), Vol. 9, pp. 1-13, PLoS One, San Francisco, CA, C1

journal

Nanomedicine based nanoparticles for neurological disorders

B Sriramoju, R Kanwar, J Kanwar

(2014), Vol. 21, pp. 4154-4168, Current medicinal chemistry, Bussum, Netherlands, C1

journal

Nanoformulated cell-penetrating survivin mutant and its dual actions

B Sriramoju, R Kanwar, J Kanwar

(2014), Vol. 9, pp. 3279-3298, International journal of nanomedicine, Auckland, New Zealand, C1

journal

Properties of bamboo fibres produced using an environmentally benign method

T Afrin, R Kanwar, X Wang, T Tsuzuki

(2014), Vol. 105, pp. 1293-1299, Journal of the textile institute, Abingdon, England, C1

journal

Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers

N Singh, S Krishnakumar, R Kanwar, C Cheung, J Kanwar

(2014), Vol. 20, pp. 578-587, Drug discovery today, London, Eng., C1

journal

Nanocapsules loaded with iron-saturated bovine lactoferrin have antimicrobial therapeutic potential and maintain calcium, zinc and iron metabolism.

I Gupta, R Sehgal, R Kanwar, V Punj, J Kanwar

(2014), pp. 1-26, Nanomedicine, London, United Kingdom, C1

journal

Bioceramic nanomaterials in medical applications

J Kanwar, G Mahidhara, K Roy, R Kanwar

(2014), pp. 163-175, Bioengineered nanomaterials, Boca Raton, Flo., B1

chapter
2013

Survivin signaling in clinical oncology : a multifaceted dragon

J Kanwar, S Kamalapuram, R Kanwar

(2013), Vol. 33, pp. 765-789, Medicinal research reviews, London, England, C1

journal

Immunomodulatory lactoferrin in the regulation of apoptosis modulatory proteins in cancer

R Kanwar, J Kanwar

(2013), Vol. 20, pp. 450-458, Protein & peptide letters, Bussum, The Netherlands, C1

journal

Targeted multimodal liposomes for nano-delivery and imaging: an avenger for drug resistance and cancer.

S Gurudevan, R Kanwar, R Veedu, S Sasidharan, R Kennedy, K Walder, N Prasad, J Kanwar

(2013), Vol. 13, pp. 322-334, Current gene therapy, Bussum, The Netherlands, C1

journal

Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers

S Dawar, N Singh, R Kanwar, R Kennedy, R Veedu, S Zhou, S Krishnakumar, S Hazra, S Sasidharan, W Duan, J Kanwar

(2013), Vol. 18, pp. 1292-1300, Drug discovery today, London, England, C1

journal

RNAi mediated Tiam1 gene knockdown inhibits invasion of retinoblastoma

N Subramanian, S Navaneethakrishnan, J Biswas, R Kanwar, J Kanwar, S Krishnakumar

(2013), Vol. 8, PLoS One, San Francisco, CA, C1

journal
2012

Milk proteins and human health

J Kanwar, R Kanwar, M Puri

(2012), pp. 1-1, Food biotechnology : principles and practices, New Delhi, India, B1-1

chapter

A novel nanoplatform for oral delivery of anti-cancer biomacromolecules

G Mahidhara, G Mahidhara, R Kanwar, R Kanwar, J Kanwar, J Kanwar

(2012), Vol. 9, pp. 942-960, International journal of nanotechnology, Olney, England, C1

journal

The origin of the antibacterial property of bamboo

T Afrin, T Tsuzuki, R Kanwar, X Wang

(2012), Vol. 103, pp. 844-849, Textile institute, Oxon, England, C1

journal

Cancer targeted nanoparticles specifically induce apoptosis in cancer cells and spare normal cells

J Kanwar, R Kanwar, G Mahidhara, H Cheung

(2012), Vol. 65, pp. 5-14, Australian journal of chemistry, Collingwood, VIC., C1

journal

Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide

J Kanwar, J Gibbons, A Verma, R Kanwar

(2012), Vol. 23, pp. 471-482, Anti-cancer drugs, Philadelphia, Pa., C1

journal

Emerging engineered magnetic nanoparticulate probes for molecular MRI of atherosclerosis : how far have we come?

R Kanwar, R Chaudhary, T Tsuzuki, J Kanwar

(2012), Vol. 7, pp. 899-916, Nanomedicine, London, England, C1

journal

Emerging engineered magnetic nanoparticulate probes for targeted MRI of atherosclerotic plaque macrophages

R Kanwar, R Chaudhary, T Tsuzuki, J Kanwar

(2012), Vol. 7, pp. 735-749, Nanomedicine, London, England, C1

journal

Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer

N Subramanian, V Raghunathan, J Kanwar, R Kanwar, S Elchuri, V Khetan, S Krishnakumar

(2012), Vol. 18, pp. 2783-2795, Molecular vision, Atlanta, Ga., C1

journal

Nanotechnology based platforms for survivin targeted drug discovery

R Samarasinghe, J Gibbons, R Kanwar, J Kanwar

(2012), Vol. 7, pp. 1083-1092, Expert opinion on drug discovery, London, England, C1

journal

Neurological disorders and therapeutics targeted to surmount the blood-brain barrier

J Kanwar, B Sriramoju, R Kanwar

(2012), Vol. 7, pp. 3259-3278, International journal of nanomedicine, Auckland, New Zealand, C1

journal

Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy

J Kanwar, G Mahidhara, R Kanwar

(2012), Vol. 7, pp. 1521-1550, Nanomedicine, London, England, C1

journal

The role of nanomedicine in cell based therapeutics in cancer and inflammation.

R Samarasinghe, R Kanwar, J Kanwar

(2012), Vol. 1, pp. 133-144, International journal of molecular and cellular medicine, Babol, Iran, C1-1

journal

Nano-lactoferrin in diagnostic, imaging and targeted delivery for cancer and infectious diseases

J Kanwar, R Samarasinghe, R Sehgal, R Kanwar

(2012), Vol. 4, pp. 31-42, Journal of cancer science & therapy, Westlake, Calif., C1-1

journal

TH17 cells in cancer related inflammation

R Kanwar, J Kanwar

(2012), pp. 43-60, Recent advances in immunology to target cancer, inflammation and infections, Rijeka, Croatia, B1-1

chapter

Immunology of Leishmaniasis and future prospective of vaccines

R Sehgal, K Goyal, R Kanwar, A Sehgal, J Kanwar

(2012), pp. 479-494, Recent advances in immunology to target cancer, inflammation and infections, Rijeka, Croatia, B1-1

chapter
2011

Antiangiogenic therapy using nanotechnological-based delivery system

J Kanwar, G Mahidhara, R Kanwar

(2011), Vol. 16, pp. 188-202, Drug discovery today, London, England, C1

journal

Lactoferrin and cancer in different cancer models

J Gibbons, R Kanwar, J Kanwar

(2011), Vol. S3, pp. 1080-1088, Frontiers in Bioscience, Albertson, N.Y., C1

journal

Novel survivin mutant protects differentiated SK-N-SH human neuroblastoma cells from activated T-cell neurotoxicity

S Baratchi, R Kanwar, J Kanwar

(2011), Vol. 233, pp. 18-28, Journal of neuroimmunology, Amsterdam, Netherlands, C1

journal

Antioxidant enzyme activities of iron-saturated bovine lactoferrin (Fe-bLf) in human gut epithelial cells under oxidative stress

H Burrow, R Kanwar, J Kanwar

(2011), Vol. 7, pp. 224-230, Medicinal chemistry, Bussum, Netherlands, C1

journal

Survivin mutant protects differentiated dopaminergic SK-N-SH cells against oxidative stress

S Baratchi, R Kanwar, J Kanwar

(2011), Vol. 6, pp. 1-8, PLoS ONE, San Francisco, Ca., C1

journal

Targeting survivin in cancer : the cell-signalling perspective

J Kanwar, J Kanwar, S Kamalapuram, S Kamalapuram, R Kanwar, R Kanwar

(2011), Vol. 16, pp. 485-494, Drug Discovery Today, London, United Kingdom, C1

journal

Nanoparticles in the treatment and diagnosis of neurological disorders : untamed dragon with fire power to heal

J Kanwar, X Sun, V Punj, B Sriramoju, R Mohan, S Zhou, A Chauhan, R Kanwar

(2011), Vol. 8, pp. 399-414, Nanomedicine : nanotechnology, biology and medicine, Philadelphia, Pa., C1

journal

Role of nanomedicine in reversing drug resistance mediated by ATP binding cassette transporters and P-glycoprotein in melanoma

J Kanwar, N Singh, R Kanwar

(2011), Vol. 6, pp. 701-714, Nanomedicine, London, England, C1

journal

Targeting hepatitis B virus and human papillomavirus induced carcinogenesis : novel patented therapeutics

R Kanwar, N Singh, S Gurudevan, J Kanwar

(2011), Vol. 6, pp. 158-174, Recent patents on anti-infective drug discovery, Bussum, Netherlands, C1

journal

The use of cyclodextrins nanoparticles for oral delivery

J Kanwar, B Long, R Kanwar

(2011), Vol. 18, pp. 2079-2085, Current medicinal chemistry, Hilversum, The Netherlands, C1

journal

Toll like receptors play a role in general immunity, eye infection and inflammation : TLRs for nanodelivery

J Kanwar, S Zhou, S Gurudevan, C Barrow, R Kanwar

(2011), Vol. 2, pp. 1-10, Journal of clinical and cellular immunology, Los Angeles, Calif., C1

journal

Chimeric aptamers in cancer cell-targeted drug delivery

J Kanwar, K Roy, R Kanwar

(2011), Vol. 46, pp. 459-477, Critical reviews in biochemistry and molecular biology, London, England, C1

journal

Effect of selenium-saturated bovine lactoferrin (Se-bLF) on antioxidant enzyme activities in human gut epithelial cells under oxidative stress

H Burrow, R Kanwar, G Mahidhara, J Kanwar

(2011), Vol. 11, pp. 762-771, Anti-cancer agents in medicinal chemistry, Bussum, Netherlands, C1

journal
2010

Survivin : a target from brain cancer to neurodegenerative disease

S Baratchi, R Kanwar, J Kanwar

(2010), Vol. 45, pp. 535-554, Critical reviews in biochemistry and molecular biology, London, England, C1

journal

Targeting survivin in cancer : patent review

J Kanwar, S Kamalapuram, R Kanwar

(2010), Vol. 20, pp. 1723-1737, Expert opinion on therapeutic patents, London, England, C1

journal

Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases

J Kanwar, R Mohan, R Kanwar, K Roy, R Bawa

(2010), Vol. 5, pp. 1435-1445, Nanomedicine, London, England, C1

journal

Proliferative and protective effects of SurR9-C84A on differentiated neural cells.

S Baratchi, R Kanwar, C Cheung, J Kanwar

(2010), Vol. 227, pp. 120-132, Journal of neuroimmunology, Amsterdam, Netherlands, C1

journal

Recent advances on the possible neuroprotective activities of Epstein-Barr virus oncogene BARF1 protein in chronic inflammatory disorders of central nervous system

A Wynne, R Kanwar, R Khanna, J Kanwar

(2010), Vol. 8, pp. 268-275, Current neuropharmacology, Sharjah, United Arab Emirates, C1

journal

MicroRNA in human cancer and chronic inflammatory diseases

J Kanwar, G Mahidhara, R Kanwar

(2010), Vol. 2, pp. 1113-1126, Frontiers in bioscience (scholar edition), Albertson, N.Y., C1

journal

Recent advances in anti-survivin treatments for cancer

R Kanwar, C Cheung, J Chang, J Kanwar

(2010), Vol. 17, pp. 1509-1515, Current medicinal chemistry, Hilversum, The Netherlands, C1

journal

Applications of nanomedicine in antibacterial medical therapeutics and diagnostics

L Matthews, R Kanwar, S Zhou, V Punj, J Kanwar

(2010), Vol. 3, pp. 1-9, Open tropical medicine journal, Amsterdam, The Netherlands, C1-1

journal
2009

Ribosome inactivating proteins (RIPs) from momordica charantia for anti viral therapy

M Puri, I Kaur, R Kanwar, R Gupta, A Chauhan, J Kanwar

(2009), Vol. 9, pp. 1080-1094, Current molecular medicine, Bussum, Netherlands, C1

journal

Molecular and biotechnological advances in milk proteins in relation to human health

J Kanwar, R Kanwar, X Sun, V Punj, H Matta, S Morley, A Parratt, M Puri, R Sehgal

(2009), Vol. 10, pp. 308-338, Current protein and peptide science, Bussum, Netherlands, C1

journal

Gut health immunomodulatory and anti-inflammatory functions of gut enzyme digested high protein micro-nutrient dietary supplement-Enprocal

J Kanwar, R Kanwar

(2009), Vol. 10, pp. 1-19, BMC immunology, London, England, C1

journal

Recent advances on the roles of NO in cancer and chronic inflammatory disorders

J Kanwar, R Kanwar, H Burrow, S Baratchi

(2009), Vol. 16, pp. 2373-2394, Current medicinal chemistry, Bussum, Netherlands, C1

journal

Recent advances of metal binding protein lactoferrin as an anti-microbial agent

I Gupta, R Sehgal, R Kanwar, A Sehgal, J Kanwar

(2009), Vol. 5, pp. 226-233, Current bioactive compounds, Bussum, Netherlands, C1

journal

Recent advances in nanoneurology for drug delivery to the brain

J Kanwar, R Kanwar, G Mahidhara

(2009), Vol. 5, pp. 441-447, Current nanoscience, Bussum, Netherlands, C1

journal

Promises of nanotechnology for drug delivery to brain in neurodegenerative diseases

S Baratchi, R Kanwar, K Khoshmanesh, P Vasu, C Ashok, M Hittu, A Parratt, S Krishnakumar, X Sun, S Sahoo, J Kanwar

(2009), Vol. 5, pp. 15-25, Current Nanoscience, Bussum, Netherlands, C1

journal
2008

Bovine milk fat enriched in conjugated linoleic and vaccenic acids attenuates allergic airway disease in mice

R Kanwar, A MacGibbon, P Black, J Kanwar, A Rowan, M Vale, G Krissansen

(2008), Vol. 38, pp. 208-218, Clinical and experimental allergy, Oxford, England, C1

journal

'Iron-saturated' lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy

J Kanwar, K Palmano, X Sun, R Kanwar, R Gupta, N Haggarty, A Rowan, S Ram, G Krissansen

(2008), Vol. 86, pp. 277-288, Immunology and cell biology, London, England, C1

journal
2006

A pseudosymmetric cell adhesion regulatory domain in the ?7 tail of the integrin ?4?7 that interacts with focal adhesion kinase and src

G Krissansen, J Singh, R Kanwar, Y Chan, E Leung, K Lehnert, J Kanwar, Y Yang

(2006), Vol. 36, pp. 2203-2214, European journal of immunology, Weinheim, Germany, C1-1

journal
2004

Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis

J Kanwar, R Kanwar, G Krissansen

(2004), Vol. 127, pp. 1313-1331, Brain : a journal of neurology, Oxford, England, C1-1

journal
2003

Mucosal vascular addressin cell adhesion molecule-1 is expressed outside the endothelial lineage on fibroblasts and melanoma cells

E Leung, R Kanwar, J Kanwar, G Krissansen

(2003), Vol. 81, pp. 320-327, Immunology and cell biology, Basingstoke, England, C1-1

journal

Requirements for ICAM-1 immunogene therapy of lymphoma.

J Kanwar, R Berg, Y Yang, R Kanwar, L Ching, X Sun, G Krissansen

(2003), Vol. 10, pp. 468-476, Cancer gene therapy, London, England, C1-1

journal
2001

Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci

J Kanwar, R Kanwar, S Pandey, L Ching, G Krissansen

(2001), Vol. 61, pp. 1948-1956, Cancer research, Birmingham, Ala., C1-1

journal

Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice

R Kanwar, J Kanwar, D Wang, D Ormrod, G Krissansen

(2001), Vol. 21, pp. 1991-1997, Arteriosclerosis thrombosis and vascular biology, Philadelphia, Pa., C1-1

journal

Effects of survivin antagonists of growth of established tumors and B7-1 immunogene therapy

J Kanwar, W Shen, R Kanwar, R Berg, G Krissansen

(2001), Vol. 93, pp. 1541-1552, Journal of the National Cancer Institute, Oxford, England, C1-1

journal
2000

Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression.

J Kanwar, R Kanwar, D Wang, G Krissansen

(2000), Vol. 78, pp. 641-645, Immunology and cell biology, London, England, C1-1

journal
1995

Calcium and protein kinase C play an important role in Campylobacter jejuni-induced changes in Na+ and Cl- transport in rat ileum in vitro

R Kanwar, N Ganguly, L Kumar, J Rakesh, D Panigrahi, B Walia

(1995), Vol. 1270, pp. 179-192, Biochimica et biophysica acta, Amsterdam, The Netherlands, C1-1

journal
1994

Impairment of Na+,K+-ATPase activity following enterotoxigenic Campylobacter jejuni infection: changes in Na+, Cl-- and 3-O-methyl-D-glucose transport in vitro, in rat ileum

R Kanwar, N Ganguly, J Kanwar, L Kumar, B Walia

(1994), Vol. 124, pp. 381-385, FEMS microbiology letters, Oxford, England, C1-1

journal

Significance of detection of immune-complexed 8 kDa hydatid-specific antigen for immunodiagnosis of hydatidosis

J Kanwar, R Kanwar, A Grewal, V Vinayak

(1994), Vol. 9, pp. 231-236, FEMS immunology & medical microbiology, Oxford, England, C1-1

journal

Purification and partial immunochemical characterization of a low molecular mass, diagnostic Echinococcus granulosus immunogen for sheep hydatidosis

J Kanwar, R Kanwar

(1994), Vol. 9, pp. 101-107, FEMS immunology & medical microbiology, Oxford, England, C1-1

journal
1993

Studies on the pathophysiological mechanism of Campylobacter jejuni-induced fluid secretion in rat ileum

R Kaur, N Ganguly, L Kumar, B Walia

(1993), Vol. 111, pp. 327-330, FEMS microbiology letters, Amsterdam, Netherlands, C1-1

journal

Funded Projects at Deakin

Australian Competitive Grants

Anti-tumour and anti-microbial activities of orally administered Fe-saturated lactoferrin: a potential alternative medicine

Prof Jagat Kanwar, Dr Rupinder Kanwar

DIISR Grant - Australia-India Strategic Research Fund - Department of Innovation, Industry and Regional Development

  • 2011: $28,000
  • 2010: $126,000
  • 2009: $126,000

Locked nucleic acid modified aptamer-siRNA chimeric conjugates for improved chemosensitivity and eradication of cancer stem cells

Prof Jagat Kanwar, Dr Rupinder Kanwar

DIISR Grant - Australia-India Strategic Research Fund - Department of Innovation, Industry and Regional Development

  • 2015: $60,000
  • 2014: $58,030
  • 2013: $90,000
  • 2012: $88,000

Industry and Other Funding

Novel Nanocapsule Based Cancer Targeted Drug Delivery System

Dr Rupinder Kanwar, Prof Jagat Kanwar, Dr Maysaa Al-Mohammedawi

  • 2012: $20,000

Maysaa Chasib Al Mohammedawi applied to the Institute of International Education - Scholar Rescue Fund for a fellowship

Dr Rupinder Kanwar, Dr Maysaa Al-Mohammedawi

  • 2015: $34,217
  • 2014: $36,097

Supervisions

Principal Supervisor
2017

Rajeswari Raguraman

Thesis entitled: Deciphering the role of tumor microenvironment in the invasion and progression of retinoblastoma

Doctor of Philosophy (Medicine), School of Medicine

2016

Narinderbir Singh

Thesis entitled: Targeting Survivin and Molecular Regulation of De-Differentiated Grade IV Astrocytoma (Glioblastoma)

Doctor of Philosophy (Medicine), School of Medicine

2015

Ajay Ashok

Thesis entitled: Novel Protein and Atenolol Co-Encapsulated Nanocapsules to Impede Cardiomyocyte Apoptosis

Doctor of Philosophy (Medicine), School of Medicine

Jessica Gibbons

Thesis entitled: Bovine lactoferrin targets apoptotic and EGFR mechanisms in breast cancer

Doctor of Philosophy (Medicine), School of Medicine

Jayanth Surya Narayanan Shankara Narayanan

Thesis entitled: Molecular regulation of survivin targeted nano-therapy in advanced prostate cancer

Doctor of Philosophy (Medicine), School of Medicine

Neha Singh

Thesis entitled: A natural biodrug targeting melanomas with vaying mutational status

Doctor of Philosophy (Medicine), School of Medicine

2014

Jaisy Samuel

Thesis entitled: Targeting the sodium iodide symporter (NIS) and apoptotic genes in extrathyroidal tumors

Doctor of Philosophy (Medicine), School of Medicine

Sneha Gurudevan

Thesis entitled: Lactoferrin targets hypoxia inducible factor - 1¿ (HIF-1¿) signaling in liver and colon cancer cells

Doctor of Philosophy (Medicine), BioDeakin

2013

Fawzi Ebrahim

Thesis entitled: Studies on the anticancer potential of high molecular weight bovine lactoferrin in targeting ovarian carcinoma

Master of Science (Biology & Chemistry), BioDeakin

Co-supervisor
2017

Harshali Anant Patil

Thesis entitled: Mutation profiling of colorectal cancer for KRAS, BRAF, NRAS and PIK3CA genes in Indian patient cohort

Doctor of Philosophy (Life & Env), School of Life and Environmental Sciences

Associate Supervisor
2017

Mohamed Ayman Abdelhamid Abdel Aboda

Thesis entitled: Multimodal Therapy and Molecular Exosomal-microRNA Biomarkers for Cancer Cachexia

Doctor of Philosophy (Medicine), School of Medicine

Prasanna Kumar Athyala

Thesis entitled: Oligonucleotide-Conjugates for Targeting EpCAM Positive Tumor Cells

Doctor of Philosophy (Medicine), School of Medicine

2015

Rajneesh Chaudhary

Thesis entitled: Zinc doped ferrite magnetic resonance imaging contrast agent for atherosclerosis

Doctor of Philosophy (Medicine), School of Medicine

Nithya Subramanian

Thesis entitled: MOLECULAR INSIGHTS AND OLIGONUCLEOTIDE BASED TARGETED GENE THERAPY AGAINST CANCER

Doctor of Philosophy (Medicine), School of Medicine

Nihal Ganesh Maremanda

Thesis entitled: Proteomics based biomarker discovery in oral cancer

Doctor of Philosophy (Medicine), School of Medicine

2014

Sishir Kumar Kamalapuram

Thesis entitled: Multimodal therapeutic protein nanocapsules for cancer therapy and imaging

Doctor of Philosophy (Medicine), School of Medicine

Bhasker Sriramoju

Thesis entitled: SurR9-C84A mutant nanocarrier and milk protein therapeutics for neurological disorders

Doctor of Philosophy (Medicine), School of Medicine

Rasika Samarasinghe

Thesis entitled: Anti-inflammatory and chondroprotectivity of dominant-negative survivan and nutraceuticals, lactoferrin and herbs

Doctor of Philosophy (Medicine), School of Medicine

2013

Isha Gupta

Thesis entitled: Anti-microbial activities of novel nanoformulated lactoferrin through oral administration

Doctor of Philosophy (Medicine), School of Medicine

2012

Tarannum Afrin

Thesis entitled: Ecofriendly production of bamboo fibres having UV-screening and antibacterial properties

Doctor of Philosophy (Engineering), Institute for Frontier Materials

Yogesh Patel

Thesis entitled: Silk as novel nano-carrier for delivering anti-cancer biomolecule lactoferrin

Master of Science (Biology & Chemistry), BioDeakin

VNL Ganesh Mahidhara

Thesis entitled: Anti-cancer nanocarriers for oral delivery of therapeutic proteins

Doctor of Philosophy (Engineering), BioDeakin

2011

Hannah Burrow

Thesis entitled: Bovine Lactoferrin: Potential Antioxidant Effector Molecule in Colon Carcinoma

Doctor of Philosophy (Biol & Chem), BioDeakin

Sara Baratchi

Thesis entitled: Protective and Proliferative Effects of Surviving Mutant on Differentiated Neuroblastoma Cells

Doctor of Philosophy (Life & Env), BioDeakin